4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-049820
Options or other derivatives
- Director acquired 0 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Chambers Michael Andrew · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-13 | Grant or award : show line 1 in the form Convertible Senior Notes | +0 | $20,000,000.00 | $0 | I |
Loading xslF345X03/doc4.xml…